SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-23-008737
Filing Date
2023-03-31
Accepted
2023-03-31 10:49:44
Documents
107
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K acrx20221231_10k.htm   iXBRL 10-K 2425721
2 EXHIBIT 23.1 ex_491036.htm EX-23.1 2389
3 EXHIBIT 31.1 ex_491037.htm EX-31.1 7715
4 EXHIBIT 31.2 ex_491038.htm EX-31.2 7722
5 EXHIBIT 32.1 ex_491041.htm EX-32.1 5460
  Complete submission text file 0001437749-23-008737.txt   12018075

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acrx-20221231.xsd EX-101.SCH 113572
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20221231_cal.xml EX-101.CAL 67117
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20221231_def.xml EX-101.DEF 766893
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20221231_lab.xml EX-101.LAB 632991
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20221231_pre.xml EX-101.PRE 807531
101 EXTRACTED XBRL INSTANCE DOCUMENT acrx20221231_10k_htm.xml XML 1960925
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35068 | Film No.: 23784289
SIC: 2834 Pharmaceutical Preparations